Kallikrein 7 anticorps (C-Term)
Aperçu rapide pour Kallikrein 7 anticorps (C-Term) (ABIN652198)
Antigène
Voir toutes Kallikrein 7 (KLK7) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 157-187, C-Term
-
Purification
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
-
Immunogène
- This Kallikrein 7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 157-187 amino acids from the C-terminal region of human Kallikrein 7.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000. IHC-P: 1:10~50. FC: 1:10~50
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Date de péremption
- 6 months
-
-
- Kallikrein 7 (KLK7)
-
Sujet
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. The KLK7 enzyme is thought to be involved in the proteolysis of intercellular cohesive structures preceding desquamation, which is the shedding of the outermost layer of the epidermis.
-
Poids moléculaire
- 27525
-
ID gène
- 5650
-
NCBI Accession
- NP_001193982, NP_001230055, NP_005037, NP_644806
-
UniProt
- P49862
-
Pathways
- Système du Complément
Antigène
-